Reuters – French drugmaker Sanofi-Aventis SA has warned that its antidepressant Norpramin should be given with extreme caution to patients with a history of certain heart problems, the U.S. Food and Drug Administration said on Wednesday.
December 4, 2009
No Comments »
No comments yet.
RSS feed for comments on this post.